Edition:
United States

Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

2,586JPY
23 Feb 2017
Change (% chg)

¥14 (+0.54%)
Prev Close
¥2,572
Open
¥2,582
Day's High
¥2,594
Day's Low
¥2,573
Volume
711,700
Avg. Vol
2,521,152
52-wk High
¥2,750
52-wk Low
¥2,192

Latest Key Developments (Source: Significant Developments)

Daiichi Sankyo Co Ltd reorganizes its U.S. commercial operations to support upcoming specialty pipeline
Friday, 16 Oct 2015 11:11am EDT 

Daiichi Sankyo Co Ltd <4568.T>:Daiichi sankyo, inc. reorganizes its U.S. commercial operations to support upcoming specialty pipeline.Says company will reduce expenses, including a reduction in headcount, from its U.S. commercial operations.Says company expects to eliminate 1,000 to 1,200 positions across the U.S. commercial function.Says reorganization is not focused on U.S.-based research and development functions.Daiichi sankyo co - as part of reorganization, co will reduce expenses, including a reduction in headcount, from its U.S. commercial operations.Daiichi sankyo co -eliminated jobs will come from U.S. commercial home office, in Parsippany, new jersey,sales,other positions throughout country.To reorganize U.S. commercial organization as it transitions from primary care product portfolio to differentiated specialty portfolio.  Full Article

Daiichi Sankyo completes share repurchase
Tuesday, 25 Aug 2015 07:30pm EDT 

Daiichi Sankyo Co Ltd:Completes repurchase of 20,650,900 shares of its common stock, at the price of 49,999,930,971 yen in total, on Aug. 25.  Full Article

Daiichi Sankyo issues mid-year and year-end dividend forecasts for FY 2016
Thursday, 14 May 2015 12:00am EDT 

Daiichi Sankyo Co Ltd:Issues mid-year dividend forecast of 40 yen per share, for FY ending March 2016.Issues year-end dividend forecast of 30 yen per share, for FY ending March 2016.  Full Article

Daiichi Sankyo to repurchase shares
Thursday, 14 May 2015 12:00am EDT 

Daiichi Sankyo Co Ltd:To repurchase up to 28,000,000 shares, representing a 3.98 pct stake.Says share repurchase up to May 15 to Aug. 31.  Full Article

Daiichi Sankyo raises consolidated full-year outlook for FY 2015
Tuesday, 28 Apr 2015 02:30am EDT 

Daiichi Sankyo Co Ltd:Says the company increased the consolidated full-year outlook for revenue to 919,000 million yen from 900,000 million yen for FY ended March 2015.Sees a decrease of operating profit forecast to 74,000 million yen from 100,000 million yen.Sees a decrease of profit before tax forecast to 79,000 million yen from 100,000 million yen.Sees a decrease of net profit attributable to parent company's shareholders forecast to 46,000 million yen from 65,000 million yen.Sees a decrease of earnings per share to 65.34 yen from 92.33 yen.FY 2015 revenues of 936.03 billion yen, net income of 71.77 billion yen – Thomson Reuters I/B/E/S.Comments the sales increase and impairment loss of subsidiary Plexxikon Inc are the main reasons for the forecast.  Full Article

Daiichi Sankyo Lixiana receives positive CHMP opinion in Europe
Sunday, 26 Apr 2015 08:00pm EDT 

Daiichi Sankyo Co Ltd:The European Committee for Medicinal Products for Human Use recommended approval of once-daily Lixiana.And says once-daily Lixiana receives positive CHMP opinion for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation and for the treatment and prevention of recurrent venous thromboembolism.Daiichi Sankyo looks forward to receiving approval decision by the European Commission soon, which is the basis for marketing authorisation in all European Union member states.  Full Article

Daiichi Sankyo sells stake in Sun Pharmaceutical Industries
Tuesday, 21 Apr 2015 01:45am EDT 

Daiichi Sankyo Co Ltd:Completed to sell 214,969,058 shares of India-based company Sun Pharmaceutical Industries Ltd on April 21.Holds 0 share of Sun Pharmaceutical Industries at present.  Full Article

Daiichi Sankyo to sell shares of Sun Pharmaceutical Industries Ltd
Monday, 20 Apr 2015 07:15am EDT 

Daiichi Sankyo Co Ltd:To sell entire or part of shares of India-based company Sun Pharmaceutical Industries Ltd.The company is holding 214,969,058 shares of Sun Pharmaceutical Industries.  Full Article

Daiichi Sankyo Co Ltd and Asubio Pharmaceuticals Inc merge
Wednesday, 1 Apr 2015 08:00am EDT 

Daiichi Sankyo Co Ltd:Says it will merge with its US-based sister company, Asubio Pharmaceuticals Inc.Says Asubio Pharmaceuticals' parent company, Asubio Pharma Co., Ltd, which is based in Japan, will continue to operate as wholly owned subsidiary of Daiichi Sankyo Co Ltd with focus on discovery research.  Full Article

Sun Pharmaceutical Industries acquires stake in Ranbaxy Laboratories from Daiichi Sankyo
Wednesday, 25 Mar 2015 02:30am EDT 

Daiichi Sankyo Co Ltd:Sun Pharmaceutical Industries Ltd completed acquisition of stake in Ranbaxy Laboratories, which was a 63.4 pct-owned subsidiary of Daiichi Sankyo, through stock swap, on March 24.Plan disclosed on April 7, 2014.  Full Article

More From Around the Web

BRIEF-Daiichi Sankyo and ArQule's carcinoma drug failed in late-stage trial

* Daiichi Sankyo and Arqule announce the completion of the metiv-hcc phase 3 study of tivantinib in second-line treatment of met-overexpressing hepatocellular carcinoma